Oliver Schnell
Oliver Schnell
Unknown affiliation
No verified email
Cited by
Cited by
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre …
R Stupp, ME Hegi, T Gorlia, SC Erridge, J Perry, YK Hong, KD Aldape, ...
The lancet oncology 15 (10), 1100-1108, 2014
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
M Weller, N Butowski, DD Tran, LD Recht, M Lim, H Hirte, L Ashby, ...
The Lancet Oncology 18 (10), 1373-1385, 2017
Positron emission tomography using [18F] Galacto-RGD identifies the level of integrin αvβ3 expression in man
AJ Beer, R Haubner, M Sarbia, M Goebel, S Luderschmidt, AL Grosu, ...
Clinical Cancer Research 12 (13), 3942-3949, 2006
Predictive impact of MGMT promoter methylation in glioblastoma of the elderly
G Reifenberger, B Hentschel, J Felsberg, G Schackert, M Simon, ...
International journal of cancer 131 (6), 1342-1350, 2012
MGMT promoter methylation is a strong prognostic biomarker for benefit from dose-intensified temozolomide rechallenge in progressive glioblastoma: the DIRECTOR trial
M Weller, G Tabatabai, B Kästner, J Felsberg, JP Steinbach, A Wick, ...
Clinical cancer research 21 (9), 2057-2064, 2015
Imaging of integrin αvβ3 expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomography
O Schnell, B Krebs, J Carlsen, I Miederer, C Goetz, RH Goldbrunner, ...
Neuro-oncology 11 (6), 861-870, 2009
Postprandial hyperglycemia and glycemic variability: should we care?
E Standl, O Schnell, A Ceriello
Diabetes care 34 (Supplement 2), S120-S127, 2011
Molecular markers in low-grade gliomas: predictive or prognostic?
C Hartmann, B Hentschel, M Tatagiba, J Schramm, O Schnell, C Seidel, ...
Clinical Cancer Research 17 (13), 4588-4599, 2011
Expression of Integrin αvβ3 in Gliomas Correlates with Tumor Grade and Is not Restricted to Tumor Vasculature
O Schnell, B Krebs, E Wagner, A Romagna, AJ Beer, SJ Grau, N Thon, ...
Brain pathology 18 (3), 378-386, 2008
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a …
U Herrlinger, T Tzaridis, F Mack, JP Steinbach, U Schlegel, M Sabel, ...
The lancet 393 (10172), 678-688, 2019
A new look at the heart in diabetes mellitus: from ailing to failing
E Standl, O Schnell
Diabetologia 43 (12), 1455-1469, 2000
Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC)
C Schichor, T Birnbaum, N Etminan, O Schnell, S Grau, S Miebach, ...
Experimental neurology 199 (2), 301-310, 2006
Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas
EM Grasbon‐Frodl, FW Kreth, M Ruiter, O Schnell, K Bise, J Felsberg, ...
International journal of cancer 121 (11), 2458-2464, 2007
Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine–DNA Methyltransferase Nonmethylated Glioblastoma: The …
U Herrlinger, N Schäfer, JP Steinbach, A Weyerbrock, P Hau, ...
Journal of Clinical Oncology 34 (14), 1611-1619, 2016
Alpha-glucosidase inhibitors 2012–cardiovascular considerations and trial evaluation
E Standl, O Schnell
Diabetes and Vascular Disease Research 9 (3), 163-169, 2012
A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma
M Westphal, O Heese, JP Steinbach, O Schnell, G Schackert, M Mehdorn, ...
European journal of cancer 51 (4), 522-532, 2015
FET–PET for malignant glioma treatment planning
M Niyazi, J Geisler, A Siefert, SB Schwarz, U Ganswindt, S Garny, ...
Radiotherapy and Oncology 99 (1), 44-48, 2011
5‐Aminolevulinic acid‐induced protoporphyrin IX levels in tissue of human malignant brain tumors
A Johansson, G Palte, O Schnell, JC Tonn, J Herms, H Stepp
Photochemistry and photobiology 86 (6), 1373-1378, 2010
Chromium in metabolic and cardiovascular disease
M Hummel, E Standl, O Schnell
Hormone and metabolic research 39 (10), 743-751, 2007
Mapping microglia states in the human brain through the integration of high-dimensional techniques
R Sankowski, C Böttcher, T Masuda, L Geirsdottir, E Sindram, ...
Nature neuroscience 22 (12), 2098-2110, 2019
The system can't perform the operation now. Try again later.
Articles 1–20